An Overview of the Treatment of Tourette's Disorder and Tics

被引:20
作者
Parraga, Humberto C. [1 ]
Harris, Kara M. [1 ]
Parraga, Karen L. [1 ]
Balen, George M. [1 ]
Cruz, Cristina [2 ]
机构
[1] Fourth St Clin, Dept Child Psychiat, Springfield, IL USA
[2] Fourth St Clin, Dept Pediat, Springfield, IL USA
关键词
DEFICIT HYPERACTIVITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PRELIMINARY CLINICAL-EXPERIENCE; NERVOUS-SYSTEM STIMULANTS; PLACEBO-CONTROLLED TRIAL; LONG-TERM TREATMENT; DOUBLE-BLIND; METHYLPHENIDATE THERAPY; MOVEMENT-DISORDERS;
D O I
10.1089/cap.2010.0027
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: The aim of this study was to review the efficacy of various treatments for Tourette's disorder (TD) and tics. Method: This study is a historical review of the treatment modalities prior to the advent of neuroleptics. A review of double-blind and placebo-controlled clinical trials and open studies on the use of neuroleptics and selected reports was also carried out. Results: The literature review reveals that the treatment of TD and tics has evolved from an early history of marginally effective approaches to the advent of neuroleptics, which started a new era in TD and tic treatment, with a significantly broader range of effectiveness. Conclusions: Although progress has been made, the literature review nevertheless reveals a great deal of confusion as related to the clinical heterogeneity of TD and tics, differences in populations, medication-dose combinations, and outcomes. However, a role for a limited number of pharmacologic agents, combined with psychosocial approaches, has been identified. There is a need for studies in larger, diagnostically homogenous samples and for the use of more sophisticated methodology, to identify intelligible models that would allow the development of more effective treatment approaches.
引用
收藏
页码:249 / 262
页数:14
相关论文
共 128 条
[1]  
Abuzzahab F E Sr, 1973, Minn Med, V56, P492
[2]  
ADAMS JR, 2004, J NEURAL TRANSM, V11, P10
[3]   Citalopram and fluvoxamine in Tourette's disorder [J].
Bajo, S ;
Battaglia, M ;
Pegna, C ;
Bellodi, L .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (03) :230-231
[4]  
BAKER EFW, 1962, CAN MED ASSOC J, V86, P746
[5]   NALOXONE EFFECT IN TOURETTE SYNDROME [J].
BERECZ, JM ;
DYSKEN, MW ;
DAVIS, JM .
NEUROLOGY, 1979, 29 (09) :1316-1317
[6]   Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study [J].
Biederman, Joseph ;
Krishnan, Suma ;
Zhang, Yuxin ;
McGough, James J. ;
Findling, Robert L. .
CLINICAL THERAPEUTICS, 2007, 29 (03) :450-463
[7]  
BLACHE R, 1864, CHOREES GRAVES GUERI, P787
[8]  
Borison R L, 1982, Adv Neurol, V35, P377
[9]  
Brain WR, 1928, LANCET, V1, P1295
[10]  
BRISSAUD E, 1899, PRESSE MED, V13, P73